# A Study of Intranasal ChAdOx1 nCOV-19

> **NCT04816019** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 42 (actual)

## Conditions studied

- Coronavirus

## Interventions

- **BIOLOGICAL:** ChAdOx1 nCov-19

## Key facts

- **NCT ID:** NCT04816019
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04816019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04816019, "A Study of Intranasal ChAdOx1 nCOV-19". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04816019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*